PSYG — Psyence Income Statement
0.000.00%
Last trade - 00:00
- CA$2.80m
- CA$2.63m
2019 December 31st | 2020 December 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 10 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.019 | 0.093 | 11.3 | 4.51 | 6.01 |
Operating Profit | -0.019 | -0.093 | -11.3 | -4.51 | -6.01 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.019 | -0.093 | -11.3 | -4.6 | -6.08 |
Net Income After Taxes | -0.019 | -0.093 | -11.3 | -4.6 | -6.08 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.019 | -0.093 | -11.3 | -4.6 | -6.08 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.019 | -0.093 | -11.3 | -4.6 | -6.08 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.001 | -0.003 | -0.063 | -0.054 | -0.068 |
Dividends per Share |